Natco Pharma mulling acquisition in RoW market to strengthen base business
Natco Pharma is mulling acquisitions in the Rest of the World (RoW) markets to strengthen its base business. “The acquisition space is to strengthen our base business. We have the…
BackBack Natco Pharma share price rises 8% to 52 week high post Q4 results
Stock Market Today: Nacto Pharma share price gained almost 8% in the morning trade post Q4 results that were declared by the company post market hours on Monday. The Natco…
Anti-trust lawsuit against Natco Pharma over generic cancer drug dismissed in US
Natco Pharma on December 21 said anti-trust claims against it regarding a generic cancer treatment drug in the US have been dismissed. In September this year, the company had stated…
